Literature DB >> 638955

Cancer of the nasopharynx in children.

M Deutsch, R Mercado, J A Parsons.   

Abstract

The authors present 15 children with cancer of the nasopharynx. Of seven patients with primary epidermoid carcinomas, only two are alive and well. Only one of four patients with a primary soft tissue sarcoma is alive and well. Two of four patients with lymphoma of the nasopharynx are alive and well. All deaths were due to uncontrolled distant metastases. Only one patient (rhabdomyosarcoma) died with uncontrolled local disease. Radiotherapy to the primary and neck is recommended for all children with primary malignancy of the nasopharynx. Adjuvant chemotherapy may also be of value for all patients regardless of histopathology.

Entities:  

Mesh:

Year:  1978        PMID: 638955     DOI: 10.1002/1097-0142(197803)41:3<1128::aid-cncr2820410348>3.0.co;2-s

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Nasopharyngeal carcinoma: the role of the Epstein-Barr virus.

Authors:  Eugene A Chu; Julie M Wu; David E Tunkel; Stacey L Ishman
Journal:  Medscape J Med       Date:  2008-07-16

2.  Nasopharyngeal carcinoma in adolescents: a retrospective review of 42 patients.

Authors:  Said Afqir; Nabil Ismaili; Khaoula Alaoui; Samir Ahid; Jean-Pierre Lotz; Elizabeth Horn; Touria Bouhafa; Redouane Abouqal; Hassan Errihani
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-01-22       Impact factor: 2.503

Review 3.  Nasopharyngeal carcinoma.

Authors:  Bernadette Brennan
Journal:  Orphanet J Rare Dis       Date:  2006-06-26       Impact factor: 4.123

4.  Pediatric Nasopharyngeal Cancer: Case Report and Review of the Literature.

Authors:  Alejandro González-Motta; Garvin González; Yurany Bermudéz; Maria C Maldonado; Javier M Castañeda; David Lopéz; Martha Cotes-Mestre
Journal:  Cureus       Date:  2016-02-15

5.  Clinical Implications of Plasma Epstein-Barr Virus DNA in Children and Adolescent Nasopharyngeal Carcinoma Patients Receiving Intensity-Modulated Radiotherapy.

Authors:  Wenze Qiu; Xing Lv; Xiang Guo; Yawei Yuan
Journal:  Front Oncol       Date:  2020-03-31       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.